Insider track record
OtherAcross 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Discover the full record of transactions filed by Omega Fund IV, L.P.. Director active across 1 company, notably Replimune Group, Inc.. Cumulatively, 19 reports have been logged. Breakdown: 0 buy · 18 sells. Total volume traded: €6.2m. History available since 16 September 2021. The latest transaction was filed on 14 March 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations19 total
16,500 shares@ US$9.780.034% mcap2.3% of flowCommon StockSEC:0000899243-22-011332:0
34,845 shares@ US$34.540.25% mcap16.7% of flowCommon StockSEC:0000899243-21-045798:0
34,845 shares@ US$34.5416.7% of flowCommon StockSEC:0000899243-21-045798
153 shares@ US$33.500.0010% mcap0.1% of flowCommon StockSEC:0000899243-21-045302:0
153 shares@ US$33.500.1% of flowCommon StockSEC:0000899243-21-045302
153 shares@ US$33.500.1% of flowCommon StockSEC:0000899243-21-045301
153 shares@ US$33.500.0010% mcap0.1% of flowCommon StockSEC:0000899243-21-045301:0
23,235 shares@ US$33.660.16% mcap10.8% of flowCommon StockSEC:0000899243-21-044774:0
23,235 shares@ US$33.6610.8% of flowCommon StockSEC:0000899243-21-044774
11 shares@ US$33.500.0001% mcap0.0% of flowCommon StockSEC:0000899243-21-044322:0
11 shares@ US$33.500.0% of flowCommon StockSEC:0000899243-21-044322
3,817 shares@ US$33.530.026% mcap1.7% of flowCommon StockSEC:0000899243-21-043855:0
3,817 shares@ US$33.531.7% of flowCommon StockSEC:0000899243-21-043855
25,225 shares@ US$33.580.17% mcap11.5% of flowCommon StockSEC:0000899243-21-043456:0
25,225 shares@ US$33.5811.5% of flowCommon StockSEC:0000899243-21-043456
12,171 shares@ US$33.580.081% mcap5.5% of flowCommon StockSEC:0000899243-21-037893:0
12,171 shares@ US$33.585.5% of flowCommon StockSEC:0000899243-21-037893
5,537 shares@ US$32.550.036% mcap2.4% of flowCommon StockSEC:0000899243-21-036546:0
5,537 shares@ US$32.552.4% of flowCommon StockSEC:0000899243-21-036546
About Omega Fund IV, L.P.
Omega Fund IV, L.P. is an investor in Replimune Group, Inc.